Skip to main content

COFFEE SKIN CANCER: CAFFEINE CONSUMPTION LINKED WITH LOWER RISK OF BASAL CELL CARCINOMA

Image result for COFFEE SKIN CANCER
A new coffee study is showing us yet another health benefit of being a regular brew-drinker.
Researchers from Brigham and Women’s Hospital and Harvard Medical School have found that there seems to be a relationship between increased coffee intake (meaning the more, the better) and decreased risk of basal cell carcinoma — the most common skin cancer.
But researchers cautioned that if you aren’t an avid coffee drinker already, this study shouldn’t convince you to try to increase your coffee intake for the sake of protecting against skin cancer.
“However, our results add basal cell carcinoma to a list of conditions for which risk is decreased with increasing coffee consumption,” study researcher Jiali Han, Ph.D., an associate professor at Brigham and Women’s Hospital, Harvard Medical School in Boston and Harvard School of Public Health, said in a statement. “This list includes conditions with serious negative health consequences such as Type 2 diabetes and Parkinson’s disease.”
This year in the United States, there are expected to be more than 2,000,000 new cases of nonmelanoma skin cancer, according to the National Cancer Institute.
The Cancer Research study included analysis of 112,897 people who were in the Nurses’ Health Study and the Health Professionals Follow-up Study. Over a 20-year period, 22,786 people developed basal cell carcinoma.
Researchers not only found a link between increased coffee consumption and decreased skin cancer risk — for example, women who drank three or more cups of coffee a day had a lower risk of skin cancer than people who drank less than a cup of coffee a month — but also a link between overall increased caffeine consumption (like from coffee, soda, chocolate, and tea) and decreased skin cancer risk. Meanwhile, there was no link between decaffeinated coffee consumption and risk of the skin cancer.
Top of Form
Bottom of Form
In addition, there was no link was identified between increased coffee or caffeine consumption and squamous cell carcinoma or melanoma, which are two other kinds of skin cancer.
“These results really suggest that it is the caffeine in coffee that is responsible for the decreased risk of basal cell carcinoma associated with increasing coffee consumption,” Han said in the statement. “This would be consistent with published mouse data, which indicate caffeine can block skin tumor formation. However, more studies in different population cohorts and additional mechanistic studies will be needed before we can say this definitively.”
However, there is such a thing as too much caffeine. The Mayo Clinic says that consuming heavy amounts of caffeine each day (500 to 600 milligrams a day, or more) can lead to muscle tremors, insomnia, irritability, restlessness and even upset stomach. But the Mayo Clinic did note that getting about 200 to 300 milligrams of caffeine per day — that which is in about four cups of coffee — for adults is not a detriment to health.
Recently, a study of about 200,000 people in the journal CANCER showed that there may be a link between taking anti-inflammatory drugs and skin cancer risk.
Researchers from the Aarhus University Hospital in Denmark found that people in the study with more than two NSAID prescriptions had a 15 percent lower risk for squamous cell carcinoma, a kind of skin cancer, as well as a 13 percent lower risk for malignant melanoma, a deadly form of cancer. This is compared with people who only filled two or fewer NSAID prescriptions.
The decreased skin cancer risk was especially pronounced when the people took them for at least seven years, and with “high-intensity use,” researchers said in the study.

Comments

Post a Comment

Popular posts from this blog

HYFRECATORS AND INTERFERENCE WITH IMPLANTABLE CARDIAC DEVICES

Investigation of Hyfrecators and They are In Vitro Interference with Implantable Cardiac Devices CHRISTOPHER WEYER, DO,* RONALD J. SIEGLE, MD,†‡ AND GUILLAUME GIRARD P. ENG, EMI-EMC§ BACKGROUND Guidelines exist for minimizing potential electromagnetic interference (EMI) with electrosurgical equipment in patients with cardiac rhythm management (CRM) devices. These guidelines encompass all electrosurgical devices but are not specific for hyfrecators. OBJECTIVE To investigate the potential interference of CRM devices by hyfrecators. MATERIALS AND METHODS Using a collagen-based saline gel, three implantable pulse generators (pacemakers) and three implantable cardioverter defibrillators were tested to measure the EMI from two commonly used hyfrecators. The six devices were tested using the hyfrecator under normal use settings and on maximum power. RESULTS Hyfrecators did not interfere with defibrillators and affected pacemakers only when used in close proximity to the devi...
Post a Comment
Read more

NEW DRUG THERAPY FOR BCC

Genentech Submits New Drug Application to FDA for Vismodegib for Rare Form of Advanced Skin Cancer Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company has submitted a New Drug Application for vismodegib to the U.S. Food and Drug Administration (FDA) for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate. Vismodegib is an investigational, oral, targeted medicine designed to selectively inhibit signaling in the Hedgehog pathway, which is implicated in more than 90 percent of BCC cases. BCC is the most common type of skin cancer, which is generally considered curable by surgery. However, when it advances, BCC can cause disfiguring and debilitating effects and can ultimately be life-threatening. “We are excited by the pivotal study results that showed vismodegib substantially reduced tumor size or healed lesions for people with this rare skin cancer, which has no approved ...
Post a Comment
Read more

TRANSACTION AND MELANOMA SURVIVAL

The rate of melanoma transaction with various biopsy techniques and the influence of tumor transaction on patient survival Mohsin Mir, MD, C. Stanley Chan, MD, Farhan Khan, MD, MBA, Bhuvaneswari Krishnan, MD, Ida Orengo, MD, and Theodore Rosen, MD Houston, Texas Background: Depth of melanoma invasion is critical because it dictates patient treatment and prognosis. Recent reports indicate melanoma transection with initial biopsy does not impact patient survival; however, tumor transaction can lead to misdiagnosis and inaccurate staging. Objective: This study assessed the rate of melanoma transaction with various biopsy techniques and the impact of tumor transaction on patient survival. Methods: We conducted a retrospective review of all melanoma cases at our institution between 2000 and 2008. Of the 490 melanoma cases identified, 479 met inclusion criteria for the study. The transaction rates of biopsy techniques were determined. Cases of transected ...
Post a Comment
Read more